Skip to main content
. 2022 Apr 16;168:51–55. doi: 10.1016/j.ejca.2022.03.013

Table 3.

Antibody response and titres among patients with cancer and controls.

Patients with cancer (N = 93) Controls (N = 186) p-value
RBD-IgG positive N (%) 78 (83.9) 179 (96.3) 0.0001
RBD-IgG titre GMT (95%CI) 2.3 (2.0–2.7) 3.2 (3.0–3.4) 0.0002
Neutralising Ab titre GMT (95%CI) 96.7 (71.3–131.2) 87.5 (74.6–102.7) 0.566

RBD, receptor-binding domain; IgG, immunoglobin G; CI, confidence interval; Ab, antibody; GMT, geometric mean.